RIO DE JANEIRO, BRAZIL - Argentina has struck a deal with drugmaker AstraZeneca Plc to receive around 22 million doses of its COVID-19 vaccine being developed with the University of Oxford, with the aim to start deliveries in the first half of next year.
The drugmaker, one of a number developing vaccines worldwide to fight the novel coronavirus, said in a statement circulated by the government on Saturday that the delivery time-frame depended on ongoing trials being successful and obtaining necessary approvals by regulatory authorities.
Argentina, which is starting to see new cases slow, is also hoping to receive . . .